Aims: To identify randomised controlled trials (RCTs) in which diabetes distress (DD) was assessed in adults under experimental conditions and to undertake meta-analysis of intervention components to determine effective interventions for reducing DD. Methods: Systematic review searching Medline, Psychinfo and Embase to March 2013 for studies measuring DD. Two reviewers assessed citations and full papers for eligibility based on RCT design and Problem Areas in Diabetes Scale or Diabetes Distress Scale outcome measure. Interventions were categorised by content and medium of delivery. Meta-analyses were undertaken by intervention category where ≥7 studies were available. Standardised mean differences and 95% confidence intervals were computed and combined in a random effects meta-analysis. 
Introduction
Living with diabetes carries with it an emotional burden with depression, anxiety and eating disorders being amongst the most widely researched. 1 A state of distress associated solely with living with diabetes, diabetes distress (DD), has developed prominence in the literature over the last decade [2] [3] [4] [5] [6] [7] particularly in Type 2 populations, although its measurement has been possible since the publication of the Problem Areas in Diabetes Scale (PAID) in 1995. 8 The PAID scale has been widely validated and used in research studies. [3] [4] [5] [6] [7] It has 20 items and scores on a 0-100 scale. A PAID score of ≥40 is widely accepted to indicate elevated distress, 5, 9 which is one standard deviation above the mean for patients with diabetes. 10 More recently the Diabetes Distress Scale (DDS) has been published with some of the same authors with 17 items a 0-4 response scale and a threshold for distress of 2.5. 11 Diabetes distress (DD) is characterised by emotional distress in relation to diabetes and its management and has four domains (or sub-scales) of emotional burden, regimen-related distress, diabetesrelated interpersonal distress and physician-related distress. 11 These four sub-scale domains have reliability and validity and have been employed in research. 12, 13 For people with elevated DD, self-management and the control of glycaemia is a substantial emotional burden. In the UK, 81% of primary care patients with Type 2 report 'some degree' of DD 14 and the point prevalence in the community of significant DD is 18%, which increases to almost 30% when any presentation over an 18 months period was considered. 2 In Type 1, Byrne et al. 15 reported 39% of their study population to have elevated DD. The emotional problems most frequently endorsed by people with diabetes relate to worry about high blood sugar, hypoglycemia and the risk of future complications [2] [3] [4] [5] [6] 10 and feeling guilty when getting off track with self-management. [3] [4] [5] 7, 8, 14 Crucially, recent work has indicated that only DD demonstrates an independent concurrent association with HbA1c and a time concordant association in which fluctuations in DD correspond with changes in HbA1c over time. 16, 17 The average reduction in DD corresponds with a clinically significant reduction in HbA1c. 18, 19 That DD interferes with selfcare in diabetes is supported by clinical observation of one of the authors 20 although longitudinal evidence is conflicting in this association. 17, 21 Evidence has demonstrated a strong association between depression and DD. 6, 7 However, some research has reported that it is depressive symptom severity, rather than major depressive disorder, with which DD is principally related. 7, 16 Recent literature has suggested that DD is more prevalent than major depressive disorder in diabetes 2 which has prompted calls for intervention endeavours to shift from those solely for depression towards targeting DD as a means of improving well-being but also potentially facilitating change in self-management behaviours and important clinical outcomes in diabetes. 22, 23 Interventions specifically targeting DD are greatly understudied offering little to inform clinicians how to intervene to reduce DD. DD has been regularly assessed as a secondary outcome in experimental studies [24] [25] [26] [27] [28] and these studies may collectively indicate intervention components, not originally designed to target DD, which did so nonetheless. The objective of this paper is to identify experimental studies in which DD was reduced following experimental intervention and to identify the intervention components and characteristics that resulted in clinically significant effect sizes.
Methods
A systematic review of randomised controlled trials was undertaken using the Preferred Reporting Items for Systematic Reviews and Meta-analyses [PRISMA] guidelines. 29 Population was any adult population with diagnosed Type 1 or 2 diabetes, where DD was assessed, irrespective of the intervention focus and the primary outcome.
Data sources and searches
A review of outcome measures assessing DD was undertaken at the outset 30 which resulted in the identification of a small number of outcome measures to assess DD. Because several measures were not widely used and/or fully validated, we only included studies which had used the full Problem Area in Diabetes Scale [PAID] 8 or the DDS. 11 Medline, Psychinfo and Embase databases were searched from 1995 to March 2013 for relevant citations with no language restrictions. The search strategy (available from the authors) was designed to capture the different terms attributed to the person's experience of diabetes tapped into by these measures of DD, for example stress, quality of life, diabetes problems, diabetes emotions. Each citation was assessed by two investigators. We did not employ randomised controlled trial (RCT) filters because we were interested in capturing all studies measuring DD. This paper reports only those studies that we identified as RCTs during citation and abstract assessments. All citations/abstracts were assessed for inclusion by two researchers.
Data extraction and quality assessment Data were extracted by one investigator and quality checked by a second on population and setting, sample size, follow up points, DD measure, outcome data for DD and glycaemic control, experimental and comparison intervention characteristics, including, use of theory, content, medium of delivery, interventionist, focus and intensity. No investigator extracted data from their own included study. Authors were contacted once to request missing outcome data. Where multiple arms were reported, the intervention identified by authors as the most and least active was included. Where studies were reported in more than one paper, they were collated such that the unit of interest was at the study rather than publication level. Studies were excluded from metaanalysis if mixed diabetes populations could not be separated in the results or trials were of equivalence design. We used the Cochrane Collaboration tool for assessing risk of bias 31 to assess for high, unclear or low risk of bias in the adequacy of reporting of sequence generation, allocation sequence concealment, blinding of outcome assessors and outcome data. Assessments were undertaken on all included studies by one author and a 10% sample independently assessed by a second author.
Data synthesis and analysis
Once intervention data were extracted, we built category descriptors (Table 1 ) and these categories formed the basis of our meta-analyses. This resulted in 6 intervention categories and 40 components. Meta-analysis was undertaken where ≥7 studies were available for each analysis enabling 21 meta-analyses including 3 main categories, 3 medium of intervention delivery and 15 analyses of potentially important intervention components effecting DD outcome. The PAID and the DDS were developed by some of the same investigators and, in their respective theoretical justifications and at the item level, similarities between the scales are discernable. Subgroup analysis based on outcome measure was not possible owing to insufficient distribution of studies across the subgroups so in view of aforementioned context we conducted the analysis on the combined data set. DD and HbA1c are reported as continuous data, therefore the mean and standard deviation at baseline and follow up were extracted for each intervention and each outcome. Standardised difference in means (SMDs) and 95% confidence intervals (95% CIs) were then computed based on the endpoint DD data for each study. Some heterogeneity was anticipated and SMDs were combined in a random effects meta-analysis. Effect heterogeneity was assessed by visual inspection of forest plots and statistical test; Chi-squared (X 2 ), and quantified using the I² index. 32 Percentages of 25, 50 and 75 indicate low, medium and high heterogeneity, respectively. Risk of publication bias was assessed by visual inspection of funnel symmetry in the plots of each trial's SMD against its SE (i.e. funnel plot). Effect sizes of 0.2, 0.5 and 0.8 are conventionally interpreted as small, medium and large, respectively. 33, 34 An effect size of 0.15 was considered clinically important because it would be expected that 6% of the diabetes population would do better than by chance alone (i.e. U3 = .56).
Results

Study selection
The search revealed 16 627citations, 1077 full text papers were retrieved and 298 papers representing 188 unique Table 3 .
Content categories: Psycho-education was the only content category which significantly reduced DD compared to controls (Fig. 2) . Psychological, diabetes selfmanagement education and care/case management categories did not significantly improve DD. There were only three studies in the drugs/devices category and on individual inspection of the outcomes, DD was found to be higher in the experimental arm at follow up (SMD 0. Medium of delivery categories: The format of delivery categories, involving combinations of face to face, remotely delivered and technologically delivered content, did not significantly influence DD outcomes.
Potentially important components: Interventions delivered by generalist clinicians located in primary care resulted in significant DD reductions. Interventions delivered by diabetes specialists, typically working in hospital settings, were not associated with significant reductions (SMD −0.06 [−0.13, 0.01]). Observation of five of the six psychologist delivered interventions indicated that the psychologist as interventionist reduced DD significantly relative to control interventionists. Neither group vs. individual formats, the clinical focus of the intervention (e.g. mood, weight loss, glycemic control) nor the presence/absence of theory in driving the intervention effected DD outcome. Intervention intensity of ≥6 intervention sessions and duration of ≥13 weeks reduced DD compared to controls. Less intensive interventions did not significantly reduce DD. Twenty-eight studies had mean baseline HbA1c over 7.5% (58.5 mmol/mol) seven of which offered motivational interviewing ( population n = 1673). In these seven studies we observed reductions in HbA1c and significant reductions in DD (−0.16 [−0.28, −0.04]). Similar borderline reductions in DD and HbA1c were observed in 11 interventions which had ≥6 sessions ( population n = 1673) (−0.13 [−0.23, −0.04]). Although statistical significance was observed, as noted in Table 3 , many of these effect sizes were below 0.15. 
Continued
Sensitivity analysis and study bias Sensitivity analyses were undertaken to assess impact of removal of Type 1 and mixed sample studies and these were negligible and did not change the overall result of meta-analysis. Risk of bias assessments demonstrated methodological flaws in many of the included studies. Twentyfour studies had a high risk of bias, 13 a moderate risk, 3 a low risk, and 1 study in which data was provided by the author was unable to be assessed. The presence of small and non-significant studies suggests that publication bias was unlikely. Risk of bias data is available from the authors.
Discussion
Our review revealed a considerable number of research studies that have measured DD indicating that researchers, clinicians and people with diabetes regard this as an important diabetes phenomenon. Psycho-education involving diabetes and mood or motivation content, delivered in any format, was significantly associated with reduced distress at follow up. Intervention delivery components which reduced DD involved general clinicians and were of both greater intensity and duration. Intensity of intervention and motivational interviewing components were found to significantly reduce both DD and HbA1c. Psychological problems usually require psychological solutions. 35, 36 DD however appears to respond to psychoeducation and affords the diabetes as well as the emotion a central therapeutic position. This might be explained in relation to improvements in diabetes management self-efficacy as there are several included studies that identify reductions in DD alongside improvements in selfefficacy. [37] [38] [39] [40] People develop mastery in relation to their diabetes management through knowledge and skill acquisition derived from the diabetes content alongside communication, reflection and motivational insights derived from the psychological components. This may enable them to experience a level of control that reduces their sense of helplessness in relation to this complex condition. Continuity and access offered by primary care may explain the significance of the generalist clinician. This finding may arise from the predominance of Type 2 studies, reflecting the importance of care close to home facilitating easy access to care, continuity of care and carer and the pastoral elements of general practice relationships. If access and continuity are important for all people with diabetes then it indicates that these outcomes may need to be a focus of interventions to reduce DD, rather than the generalist clinician per se. This is somewhat contradicted by our finding that combined face to face and remotely delivered interventions, which would facilitate access and continuity, did not appear to influence DD outcome and reinforces the finding that generalists are important.
Motivational interviewing has been widely evaluated to determine its effectiveness in promoting patient selfmanagement across a range of long-term conditions. 41, 42 With the exception of trials in diabetes in which findings have been equivocal. 43, 44 Motivational interviewing has been widely considered effective in changing healthrelated behaviours. Motivational interviewing trials in long-term conditions have assessed its effectiveness based on patient reported outcome measures (PROM) whereas diabetes trials have largely focused on evaluating change in glycemic control, a complex biological variable. In our study motivational interviewing was assessed using the PAID and the DDS which are PROMs and was found to reduce DD. In trials where this resulted, motivational interviewing also reduced elevated HbA1c. This effect was of borderline significance, however it remains unclear whether it reduces DD, despite reducing HbA1c. Nonetheless, the association between DD and glycaemia in these seven motivational interviewing trials is notable and requires further research attention.
As noted, DD was not influenced by face to face or remote delivery nor by group or 1:1 interactions. There is clinical interest currently in digital clinical communications by email, text, mobile and web portals 45, 46 with a rationale that they can improve access to health care and therefore might be expected to reduce distress. Our analysis did not find evidence for this. Face to face consultations, solely or in addition to remote access via telephone or digital methods, remained the most frequently delivered experimental intervention. Two of the three included drugs/devices interventions, a trial of insulin intensification 47 and in another of blood glucose monitoring, 48 found DD to be higher in the experimental arm at follow up raising concerns that drug and device intensification can increase DD. As diabetes care becomes increasingly technological around blood glucose monitoring, insulin delivery systems, new drugs, dose titration and web applications to record and analyse the data it is of concern to companies and clinicians that these innovations do not increase DD. The impact of new drugs/doses on health-related quality of life is now a major feature of many drug trials 49 and DD may have a place alongside in understanding the diabetes burden associated with innovations in treatments and care. This is the first review to be undertaken of the published DD literature using a comprehensive search strategy and PRISMA methods 29 resulting in the analysis of a large number of trials with statistical and clinical homogeneity. Ethnicity was reported in half of the included trials and representation of ethnic minority populations in the studies indicates that the meta-analyses broadly represents a diverse population with diabetes. The analysis process of developing intervention categories, from collections of components which could support metaanalyses, was thorough and transparent. The findings enable acceleration of experimental research targeting DD. There are a number of review limitations. DD has been variously described over two decades and only three databases were searched and it is inevitable that some studies will have been missed. In multiple arm trials, 48, [50] [51] [52] [53] [54] [55] [56] [57] we recognise limitations in selecting the most and least active intervention arms to address the issue of non-independence of effects from an individual study contributing to the meta-analysis. Cochrane advocates that a preferable approach is to define intervention and comparison arms and combine data within these newly formed groups. In the instance of RCT estimating treatment effects of complex interventions such an approach is inappropriate in view of the complex heterogeneity even between the different intervention and control arms within a single study. In effect, the unique effects of differing interventions are averaged out such that the overall estimate does not reflect something meaningful. After careful consideration of alternative approaches offered within the Cochrane handbook 58 we felt our approach to be the most appropriate means of approximating the truth. Twenty-four of our 41 included studies were assessed as having a high risk of bias. Removing these studies to undertake sensitivity analyses would have made meta-analyses by intervention category/component not possible. These many studies with a high risk of bias mean that some caution is required in interpreting the results. Most effect sizes were lower than 0.2 conventionally regarded as small by Cohen's D. 26, 27 The mean DD levels of participants in the trials were below threshold and the next research steps are to develop trials to determine effect sizes when these intervention components are targeted at people with elevated DD at baseline.
Implications for research and practice
Theory and clinical hunch have thus far been the only guidance available to clinicians and researchers in developing interventions to reduce DD. This review is signposting psycho-educational interventions with diabetes and mood/motivation content, delivered more intensively and emphasising access and continuity of care. Many psycho-educational interventions with one or more of these content elements are revealed in our review. 53, 56, [59] [60] [61] [62] [63] [64] [65] [66] Motivational interviewing may offer more opportunity in diabetes than thought previously. These now need evaluating in Type 1 and Type 2 populations with elevated distress in experimental conditions with DD distress as the primary outcome. are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
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